Clinical Trial Update: Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the safety and dosing of photodynamic therapy with lutetium texaphyrin in patients with locally recurrent prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Lutetium texaphyrin (lutetium texaphyrin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 1 | Status: TERMINATED